Cabia, James P.
HRN: 16-00-63 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2023
CEFUROXIME 1.5GM (VIAL)
05/08/2023
05/15/2023
IV
1.5g
Q8hrs
Lacerated Wound
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes